Table 1

Clinical characteristics of human participants

ISIR
Subjects, n (female/male)18 (10/8)23 (13/10)
Age (years)35.7 ± 2.339.4 ± 2.5
BMI (kg/m2)25.8 ± 1.028.0 ± 1.2
Fasting glucose (mg/dL)87.9 ± 1.492.9 ± 1.8*
Fasting insulin (µU/mL)4.74 ± 0.429.87 ± 1.55**
SI (IVGTT)8.12 ± 0.62.80 ± 0.3**
  • Data are summarized as mean ± SEM unless otherwise indicated. Metabolic characteristics of study cohort. IVGTT, intravenous glucose tolerance test.

  • *P < 0.05; **P < 0.0005.